This is a follow up on a case of PLEVA 2 weeks after COVID-19 vaccination. The patient in this case did not have any such rash or reaction prior to the vaccine. Following the vaccine, he had a major breakout of PLEVA (acute form)has since had minor episodes of the rash due to the PLC(chronic form). This case is noteworthy is that the patient now has the PLC (chronic form) after suffering the acute form of PLEVA following is COVID-19 vaccination. Further investigation this disease would be helpful to better understand the causes and treatments. While this is an unsightly rash, It should not discourage patients from receiving the COVID-19 vaccination.
GIL‐BISTES Deborah, KLUGER Nicolas, BESSIS Didier, GUILLOT Bernard, RAISON‐PEYRON Nadia. Pityriasis lichenoides chronic after measles–mumps–rubella vaccination. The Journal of Dermatology. Vol. 39(5):492–493. 2012. Wiley. [Cross Ref]
Filippi Federica, Patrizi Annalisa, Sabattini Elena, Varotti Elisa, Bertuzzi Clara, Pileri Alessandro. Pityriasis lichenoides triggered by measles‐mumps‐rubella vaccine injection. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. Vol. 18(7):758–760. 2020. Wiley. [Cross Ref]
Bellinato F., Maurelli M., Gisondi P., Girolomoni G.. A systematic review of treatments for pityriasis lichenoides. Journal of the European Academy of Dermatology and Venereology. Vol. 33(11):2039–2049. 2019. Wiley. [Cross Ref]
Bowers Sacharitha, Warshaw Erin M.. Pityriasis lichenoides and its subtypes. Journal of the American Academy of Dermatology. Vol. 55(4):557–572. 2006. Elsevier BV. [Cross Ref]
Ankad Balachandra S., Beergouder Savitha L.. Pityriasis lichenoides et varioliformis acuta in skin of color: new observations by dermoscopy. Dermatology Practical & Conceptual. 2017. Mattioli1885. [Cross Ref]
Singh Maneesh. Pityriasis lichenoides acuta after COVID-19 vaccination. ScienceOpen. [Cross Ref]
Kuna Kasper, Szewczyk Krzysztof, Gabryelska Agata, Białasiewicz Piotr, Ditmer Marta, Strzelecki Dominik, Sochal Marcin. Potential Role of Sleep Deficiency in Inducing Immune Dysfunction. Biomedicines. Vol. 10(9)2022. MDPI AG. [Cross Ref]